HLA-DR was detected at low, medium, and high levels in melanocytes, primary melanoma, and metastatic melanoma cells, respectively, although these biopsies contained BRAF and not the NRAS mutation, which is associated with higher HLA-DR expression43,44. The gene discussed is NRAS; the disease is melanoma.